Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-06-02T05:50:53.869Z Has data issue: false hasContentIssue false
  • English
  • Français

A Comparative Study on Virology, Epidemiology, and Clinical Features of SARS and COVID-19

Published online by Cambridge University Press:  31 August 2021

Yanmei Zhao ,
Qianying Lu Open the ORCID record for Qianying Lu [Opens in a new window] ,
Xiangyan Meng ,
Siyu Huang ,
Jianfeng Zhang ,
Wenlong Dong ,
Haojun Fan  and
Shike Hou
Yanmei Zhao
Affiliation:
Institute of Disaster and Emergency Medicine, Tianjin University, Nankai District, Tianjin, P.R. China
Qianying Lu
Affiliation:
Institute of Disaster and Emergency Medicine, Tianjin University, Nankai District, Tianjin, P.R. China
Xiangyan Meng
Affiliation:
Institute of Disaster and Emergency Medicine, Tianjin University, Nankai District, Tianjin, P.R. China
Siyu Huang
Affiliation:
Institute of Disaster and Emergency Medicine, Tianjin University, Nankai District, Tianjin, P.R. China
Jianfeng Zhang
Affiliation:
Institute of Disaster and Emergency Medicine, Tianjin University, Nankai District, Tianjin, P.R. China
Wenlong Dong
Affiliation:
Institute of Disaster and Emergency Medicine, Tianjin University, Nankai District, Tianjin, P.R. China
Haojun Fan*
Affiliation:
Institute of Disaster and Emergency Medicine, Tianjin University, Nankai District, Tianjin, P.R. China
Shike Hou*
Affiliation:
Institute of Disaster and Emergency Medicine, Tianjin University, Nankai District, Tianjin, P.R. China
*
Corresponding author: Haojun Fan, Email: fanhaojun999@126.com; Shike Hou, Email: houshike@126.com
Corresponding author: Haojun Fan, Email: fanhaojun999@126.com; Shike Hou, Email: houshike@126.com
Get access Rights & Permissions [Opens in a new window]

Abstract

In December 2019, an outbreak of an unknown cause of pneumonia (later named coronavirus disease 2019 [COVID-19]) occurred in Wuhan, China. This was found to be attributed to a novel coronavirus of zoonotic origin, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously named 2019 novel coronavirus or 2019-nCoV). The SARS-CoV-2, a new type of highly pathogenic human coronavirus related to severe acute respiratory syndrome coronavirus (SARS-CoV), spread rapidly worldwide and caused 246,303,023 confirmed infections, including 4,994,160 deaths, by October 31, 2021. SARS-CoV-2 and SARS-CoV vary in their specific characteristics, regarding epidemics and pathogenesis. This article focuses on the comparison of the virology, epidemiology, and clinical features of SARS-CoV and SARS-CoV-2 to reveal their common and distinct properties, to provide an up-to-date resource for the development of advanced systems and strategies to monitor and control future epidemics of highly pathogenic human coronaviruses.

Keywords

SARSSARS-CoV-2COVID-19epidemicclinical features
Type
Commentary
Information
Disaster Medicine and Public Health Preparedness , Volume 17 , 2023 , e35
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

World Health Organization. Weekly operational update on COVID-19 - 3 November 2021. https://www.who.int/publications/m/item/weekly-operational-update-on-covid-19---3-november-2021. Published November 3, 2021. Accessed November 8, 2021.Google Scholar
Hui, DS, Menish, ZA, Zumla, A . Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulm Med. 2014;20:233-241.CrossRefGoogle ScholarPubMed
Xu, X, Chen, P, Wang, J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63:457-460.Google ScholarPubMed
Zhou, P, Yang, X, Wang, X, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-273.CrossRefGoogle ScholarPubMed
Lu, R, Zhao, X, Li, J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565-574.Google ScholarPubMed
Perlman, S. Another decade, another coronavirus. N Engl J Med. 2020;382:760-762.Google ScholarPubMed
Li, Z, Wu, M, Yao, J, et al. Caution on kidney dysfunctions of COVID-19 patients. medRxiv. 2020. doi: 10.1101/2020.02.08.20021212 Google Scholar
Xu, Z, Shi, L, Wang, Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420-422.Google ScholarPubMed
Gong, J, Dong, H, Xia, SQ, et al. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19 pneumonia. medRxiv. 2020. doi: 10.1101/2020.02.25.20025643 Google Scholar
US Food & Drug Administration. FDA approves tisagenlecleucel for B-cell ALL and tocilizumab for cytokine release syndrome. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-tisagenlecleucel-b-cell-all-and-tocilizumab-cytokine-release-syndrome. Published September 7, 2017. Accessed November 10, 2020.Google Scholar
National Health Commission of the People’s Republic of China. Notice on the issuance of the diagnosis and treatment of new coronavirus pneumonia (trial version 8). http://www.nhc.gov.cn/yzygj/s7653p/202008/0a7bdf12bd4b46e5bd28ca7f9a7f5e5a.shtml. Published August 19, 2020. Accessed November 10, 2020.Google Scholar
World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. https://www.who.int/csr/sars/country/table2004_04_21/en/. Published April 21, 2004. Accessed November 10, 2020.Google Scholar
Hui, DSC, Zumla, A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am. 2019;33:869-889.CrossRefGoogle ScholarPubMed
Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.CrossRefGoogle ScholarPubMed
Chan, JF, Yuan, S, Kok, KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514-523.Google ScholarPubMed
Wölfel, R, Corman, VM, Guggemos, W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465-469.CrossRefGoogle ScholarPubMed
Forster, P, Forster, F, Renfrew, C, et al. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A. 2020;117:9241-9243.Google ScholarPubMed
Wu, JT, Leung, K, Leung, GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395:689-697.CrossRefGoogle Scholar
National Health Commission of the People’s Republic of China. The latest situation of the new coronavirus pneumonia epidemic situation as of 24:00 on November 7th. http://www.nhc.gov.cn/xcs/yqtb/202111/f6f5a350c7cd4c93a234efbc6ff31ecd.shtml. Published November 8, 2021. Accessed November 9, 2021.Google Scholar
World Health Organization. Coronavirus disease (COVID-2019) situation reports-56. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200316-sitrep-56-covid-19.pdf?sfvrsn=9fda7db2_6. Published March 16, 2020. Accessed November 10, 2020.Google Scholar
National Health Commission of the People’s Republic of China. The latest situation of the new coronavirus pneumonia epidemic situation as of 24:00 on March 4th. http://www.nhc.gov.cn/xcs/yqtb/202003/6e02433f7786402d8ea162fb5b80b5a0.shtml. Published March 4, 2020. Accessed November 10, 2020.Google Scholar
Health Commission of Heilongjiang Province. Six special data of Suifenhe Port in Heilongjiang province. http://yiqing.ljjk.org.cn/index/pcontrol/newsinfo/id/2863.html. Published May 14, 2020. Accessed November 10, 2020.Google Scholar
Hu, Z, Song, C, Xu, C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020;63:706-711.Google ScholarPubMed
Yeo, C, Kaushal, S, Yeo, D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020;5:335-337.Google Scholar
Petersen, E, Koopmans, M, Go, U, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020;20:e238-e244.CrossRefGoogle ScholarPubMed
Li, Q, Guan, X, Wu, P. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-1207.CrossRefGoogle ScholarPubMed
Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol. 2020;41(2):145-151.Google Scholar
World Health Organization. Keep health workers safe to keep patients safe: WHO. https://www.who.int/news-room/detail/17-09-2020-keep-health-workers-safe-to-keep-patients-safe-who. Published September 17, 2020. Accessed November 12, 2020.Google Scholar
Chen, J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 2020;22(2):69-71.CrossRefGoogle ScholarPubMed
Lee, N, Hui, D, Wu, A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986-1994.Google Scholar
Peiris, JS, Yuen, KY, Osterhaus, AD, et al. The Severe Acute Respiratory Syndrome. N Engl J Med. 2003;349:2431-2441.CrossRefGoogle ScholarPubMed
Leung, GM, Hedley, AJ, Ho, L-M, et al. The epidemiology of Severe Acute Respiratory Syndrome in the 2003 Hong Kong Epidemic: an analysis of all 1755 patients. Ann Intern Med. 2004;141:662-673.Google ScholarPubMed
Lipsitch, M, Cohen, T, Cooper, B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003;300:1966-1970.Google ScholarPubMed
Riou, J, Althaus, CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020;25:2000058.CrossRefGoogle ScholarPubMed
Zhao, S, Lin, Q, Ran, J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214-217.Google ScholarPubMed
van den Driessche, P. Reproduction numbers of infectious disease models. Infect Dis Model. 2017;2:288-303.Google ScholarPubMed
Wang, D, Hu, B, Hu, C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069.Google ScholarPubMed
Guan, W, Ni, Z, Hu, Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-1720.Google ScholarPubMed
World Health Organization. Coronavirus disease (COVID-2019) situation reports-89. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200418-sitrep-89-covid-19.pdf?sfvrsn=3643dd38_2. Published April 18, 2020. Accessed April 21, 2020.Google Scholar
Pan, X, Chen, D, Xia, Y, et al. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect Dis. 2020;20:410-411.CrossRefGoogle Scholar
Qiu, C, Cui, C, Hautefort, C, et al. Olfactory and gustatory dysfunction as an early identifier of COVID-19 in adults and children: an international multicenter study. Otolaryngol Head Neck Surg. 2020;163(4):714-721.CrossRefGoogle ScholarPubMed
Qaseem, A, Yost, J, Etxeandia-Ikobaltzeta, I, et al. Should clinicians use chloroquine or hydroxychloroquine alone or in combination with azithromycin for the prophylaxis or treatment of COVID-19? Living practice points from the American College of Physicians (Version 1). Ann Intern Med. 2020;173:137-142.Google ScholarPubMed
Holshue, ML, DeBolt, C, Lindquist, S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382:929-936.Google ScholarPubMed
Grein, J, Ohmagari, N, Shin, D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382:2327-2336.CrossRefGoogle ScholarPubMed
WHO Solidarity Trial Consortium, Pan, H, Peto, R, et al. Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results. N Engl J Med. 2021;384:497-511.Google Scholar
Zhao, R, Wang, H, Wang, X, et al. Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis. Osteoporos Int. 2017;28:1027-1034.Google ScholarPubMed
National Administration of Traditional Chinese Medicine. Notice on recommending the use of “Qing-Fei-Pai-Du Decoction” in the treatment of pneumonitis infected by new coronavirus with integrated Chinese and Western medicine. http://yzs.satcm.gov.cn/zhengcewenjian/2020-02-07/12876.html. Published February 7, 2020. Accessed November 12, 2020.Google Scholar
Li, R, Hou, Y, Huang, J, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res. 2020;156:104761.Google Scholar
Wang, Z, Chen, X, Lu, Y, et al. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020;14:64-68.CrossRefGoogle ScholarPubMed
Leng, Z, Zhu, R, Hou, W, et al. Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 2020;11:216-228.CrossRefGoogle ScholarPubMed
Zhong, N. Diagnosis and treatment of SARS. Natl Med J China. 2003;83:1731-1752.Google Scholar
Li, L, Liang, X, Jiang, Q, et al. An update on the epidemiology characteristics of novel coronavirus pneumonia (COVID-19). Chin J Epidemiol. 2020;41(2):139-144.Google Scholar